U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 29

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr22:19748804
GRCh38:
Chr22:19761281
TBX1DiGeorge syndrome, Velocardiofacial syndrome, Tetralogy of Fallot
Likely pathogenic
(Dec 1, 2022)
criteria provided, single submitter
2.
GRCh37:
Chr16:50730867
GRCh38:
Chr16:50696956
NOD2Velocardiofacial syndromeUncertain significance
(Feb 13, 2023)
criteria provided, single submitter
3.
GRCh37:
Chr22:19750799
GRCh38:
Chr22:19763276
TBX1G149D, G158DVelocardiofacial syndromeUncertain significance
(May 2, 2022)
criteria provided, single submitter
4.
GRCh38:
Chr22:18948677-21110520
Velocardiofacial syndromePathogenic
(Oct 4, 2021)
criteria provided, single submitter
5.
GRCh38:
Chr22:18948676-21110520
Velocardiofacial syndrome, Short stature, Immunodeficiency,
Complete atrioventricular canal defect, Recurrent hypoglycemia, Neonatal hypoglycemia,
Generalized-onset seizure, Neonatal respiratory distress, Hypokalemia,
Decreased body weight, Neonatal inspiratory stridorAplasia of the thymus,
Maternal hypertension, ...see more
Pathogenic
(Jul 5, 2021)
criteria provided, single submitter
6.
GRCh37:
Chr22:19751852
GRCh38:
Chr22:19764329
TBX1DiGeorge syndrome, Velocardiofacial syndrome, Tetralogy of Fallot,
Conotruncal heart malformations, DiGeorge syndrome
Uncertain significance
(Dec 14, 2021)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr22:19752509
GRCh38:
Chr22:19764986
TBX1Q247R, Q238RVelocardiofacial syndrome, Conotruncal heart malformations, DiGeorge syndrome,
Tetralogy of Fallot, DiGeorge syndrome
Uncertain significance
(Mar 9, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr22:19753430
GRCh38:
Chr22:19765907
TBX1R305Q, R314QDiGeorge syndrome, Conotruncal heart malformations, Velocardiofacial syndrome,
DiGeorge syndrome, Tetralogy of Fallot
Likely benign
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
9.
GRCh37:
Chr22:19754028-19754036
GRCh38:
Chr22:19766505-19766513
TBX1Velocardiofacial syndrome, DiGeorge syndrome, Tetralogy of Fallot,
Conotruncal heart malformations, DiGeorge syndrome
Uncertain significance
(Oct 1, 2022)
criteria provided, multiple submitters, no conflicts
10.
Amyloidogenic transthyretin amyloidosisPathogenic
(Feb 15, 2021)
no assertion criteria provided
11.
GRCh37:
Chr22:19753948
GRCh38:
Chr22:19766425
TBX1A349G, A358GVelocardiofacial syndrome, Conotruncal heart malformations, DiGeorge syndrome,
Tetralogy of Fallot
Uncertain significance
(Aug 13, 2020)
criteria provided, single submitter
12.
GRCh37:
Chr22:19750829
GRCh38:
Chr22:19763306
TBX1L159P, L168PTetralogy of Fallot, Velocardiofacial syndrome, DiGeorge syndrome
Likely pathogenic
(May 16, 2018)
criteria provided, single submitter
13.
GRCh37:
Chr22:19752592
GRCh38:
Chr22:19765069
TBX1E266K, E275KDiGeorge syndrome, Tetralogy of Fallot, Conotruncal heart malformations,
Velocardiofacial syndrome, DiGeorge syndrome, not provided
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
14.
GRCh37:
Chr22:19754023-19754024
GRCh38:
Chr22:19766500-19766501
TBX1DiGeorge syndrome, Conotruncal heart malformations, Velocardiofacial syndrome,
Tetralogy of Fallot, DiGeorge syndrome
Uncertain significance
(Aug 12, 2021)
criteria provided, multiple submitters, no conflicts
15.
GRCh37:
Chr22:19754089
GRCh38:
Chr22:19766566
TBX1P396L, P405LVelocardiofacial syndrome, Conotruncal heart malformations, Tetralogy of Fallot,
DiGeorge syndrome, not specified, not provided,
DiGeorge syndrome
Uncertain significance
(Jun 27, 2022)
criteria provided, multiple submitters, no conflicts
16.
GRCh37:
Chr22:19754053
GRCh38:
Chr22:19766530
TBX1P384Q, P393QDiGeorge syndrome, Velocardiofacial syndrome, Conotruncal heart malformations,
DiGeorge syndrome, Tetralogy of Fallot
Likely benign
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr22:18661724-21505417
Velocardiofacial syndrome, DiGeorge syndromePathogenic
(Jan 1, 2019)
criteria provided, single submitter
18.
GRCh37:
Chr22:19748516-19748596
GRCh38:
Chr22:19760993-19761073
TBX1not provided, Velocardiofacial syndrome, Conotruncal heart malformations,
Tetralogy of Fallot, DiGeorge syndrome, DiGeorge syndrome
Uncertain significance
(Apr 5, 2022)
criteria provided, multiple submitters, no conflicts
19.
GRCh37:
Chr22:18919477-21800471
Velocardiofacial syndrome, DiGeorge syndromePathogenic
(Mar 2, 2019)
no assertion criteria provided
20.
GRCh37:
Chr22:18636749-21800471
Velocardiofacial syndrome, DiGeorge syndromePathogenic
(Mar 2, 2019)
no assertion criteria provided
21.
GRCh37:
Chr22:18922151-21449911
Velocardiofacial syndrome, DiGeorge syndromePathogenic
(Mar 2, 2019)
no assertion criteria provided
22.
GRCh37:
Chr22:18631364-21800471
Velocardiofacial syndrome, DiGeorge syndromePathogenic
(Mar 2, 2019)
no assertion criteria provided
23.
GRCh37:
Chr22:18912231-21465672
Velocardiofacial syndrome, DiGeorge syndromePathogenic
(Mar 2, 2019)
no assertion criteria provided
24.
GRCh37:
Chr22:19748717
GRCh38:
Chr22:19761194
TBX1Cardiovascular phenotype, Tetralogy of Fallot, Velocardiofacial syndrome,
Conotruncal heart malformations, DiGeorge syndrome
Conflicting interpretations of pathogenicity
(Dec 23, 2019)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr22:19754276
GRCh38:
Chr22:19766753
TBX1Cardiovascular phenotype, DiGeorge syndrome, Conotruncal heart malformations,
Velocardiofacial syndrome, DiGeorge syndrome, Tetralogy of Fallot
Conflicting interpretations of pathogenicity
(Oct 1, 2022)
criteria provided, conflicting interpretations
26.
GRCh37:
Chr22:19753951
GRCh38:
Chr22:19766428
TBX1G350D, G359DCardiovascular phenotype, not provided, Velocardiofacial syndrome,
Tetralogy of Fallot, Conotruncal heart malformations, DiGeorge syndrome,
DiGeorge syndrome
Conflicting interpretations of pathogenicity
(Oct 12, 2022)
criteria provided, conflicting interpretations
27.
GRCh37:
Chr18:29178618
GRCh38:
Chr18:31598655
TTRV142IATTRV122I amyloidosis, ZTTK syndrome, Carpal tunnel syndrome 1,
Amyloidogenic transthyretin amyloidosis, Hyperthyroxinemia, dystransthyretinemic, Cardiovascular phenotype,
Developmental and epileptic encephalopathy, 41, Charcot-Marie-Tooth disease, not provided,
Cardiomyopathy, Amyloid Cardiomyopathy, Transthyretin-relatedCataract 3 multiple types,
Amyloidogenic transthyretin amyloidosis, Velocardiofacial syndrome, Osteogenesis imperfecta type 11,
Cytochrome-c oxidase deficiency disease, Postural tremor, Bone marrow hypocellularity,
Anemia, Pancytopenia, See cases,
...see more
Pathogenic/Likely pathogenic
(Feb 23, 2023)
criteria provided, multiple submitters, no conflicts
28.
GRCh37:
Chr22:19751747
GRCh38:
Chr22:19764224
TBX1H194Q, H203QVelocardiofacial syndromePathogenic
(Mar 1, 2007)
no assertion criteria provided
29.
GRCh37:
Chr22:19754195-19754217
GRCh38:
Chr22:19766672-19766694
TBX1P444fs, P435fsVelocardiofacial syndromePathogenic
(May 16, 2006)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination